Scheller Richard H
SEC-identified person · CIK 1214133 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Alector, Inc. ALEC | Director | filed 2019–2026 |
| Maze Therapeutics, Inc. MAZE | Director | filed 2025–2026 |
| VG Acquisition Corp. VGAC.U | Director | filed 2021–2024 |
| Dice Therapeutics, Inc. DICE | Director | filed 2021–2023 |
| Bridgebio Pharma, Inc. BBIO | Director · See Remarks | filed 2019–2023 |
| Oric Pharmaceuticals, Inc. ORIC | Director | filed 2020–2021 |
| Xenon Pharmaceuticals Inc. XENE | Director | filed 2015–2019 |
| Genentech INC DNA | EXECUTIVE VICE PRESIDENT | filed 2006–2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.